María Isabel Longo

639 total citations
17 papers, 264 citations indexed

About

María Isabel Longo is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, María Isabel Longo has authored 17 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Dermatology and 6 papers in Oncology. Recurrent topics in María Isabel Longo's work include Nonmelanoma Skin Cancer Studies (8 papers), Skin Protection and Aging (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). María Isabel Longo is often cited by papers focused on Nonmelanoma Skin Cancer Studies (8 papers), Skin Protection and Aging (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). María Isabel Longo collaborates with scholars based in United States, Italy and Switzerland. María Isabel Longo's co-authors include Rodrigo Valdés‐Rodríguez, Colton B. Nielson, Daniel Martín-Pérez, Pablo L. Ortiz‐Romero, James R. Bischoff, Juan Fernando Martínez-Leal, María E. Rodríguez, Raquel Villuendas, B. Herreros and Miguel Á. Piris and has published in prestigious journals such as Journal of the American Academy of Dermatology, Haematologica and Journal of Neuro-Oncology.

In The Last Decade

María Isabel Longo

14 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Isabel Longo United States 10 114 100 99 74 29 17 264
Dominga Elsa Velázquez United States 8 58 0.5× 84 0.8× 103 1.0× 57 0.8× 31 1.1× 12 309
Anna Hannuksela‐Svahn Finland 5 272 2.4× 73 0.7× 138 1.4× 176 2.4× 166 5.7× 5 428
Arthur Morris United Kingdom 4 82 0.7× 41 0.4× 179 1.8× 53 0.7× 15 0.5× 6 221
Y-L. Choi South Korea 5 103 0.9× 66 0.7× 64 0.6× 51 0.7× 25 0.9× 7 265
Iñaki Zabalza Spain 8 29 0.3× 123 1.2× 172 1.7× 41 0.6× 7 0.2× 19 317
Jeffrey Zhao United States 9 63 0.6× 49 0.5× 77 0.8× 23 0.3× 25 0.9× 23 211
Marco Rubatto Italy 10 87 0.8× 47 0.5× 119 1.2× 60 0.8× 95 3.3× 30 246
David Eilers United States 9 204 1.8× 41 0.4× 114 1.2× 196 2.6× 21 0.7× 19 297
Nielsen Nh Denmark 8 57 0.5× 97 1.0× 179 1.8× 13 0.2× 13 0.4× 15 291
R.J.T. van der Leest Netherlands 9 306 2.7× 73 0.7× 313 3.2× 313 4.2× 16 0.6× 11 472

Countries citing papers authored by María Isabel Longo

Since Specialization
Citations

This map shows the geographic impact of María Isabel Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Isabel Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Isabel Longo more than expected).

Fields of papers citing papers by María Isabel Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Isabel Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Isabel Longo. The network helps show where María Isabel Longo may publish in the future.

Co-authorship network of co-authors of María Isabel Longo

This figure shows the co-authorship network connecting the top 25 collaborators of María Isabel Longo. A scholar is included among the top collaborators of María Isabel Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Isabel Longo. María Isabel Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Longo, María Isabel, et al.. (2022). Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors. Journal of the American Academy of Dermatology. 88(3). 534–542. 24 indexed citations
3.
Longo, María Isabel, et al.. (2022). Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids. Journal of the American Academy of Dermatology. 88(3). 521–530. 25 indexed citations
4.
Longo, María Isabel, et al.. (2021). Reactive angioendotheliomatosis associated with antiphospholipid syndrome. Dermatology Online Journal. 27(3). 1 indexed citations
5.
Thomas, Renee M., et al.. (2020). Scar sarcoidosis following rituximab therapy. Dermatologic Therapy. 33(6). e13693–e13693. 8 indexed citations
6.
Nielson, Colton B., et al.. (2019). Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature. Dermatologic Surgery. 45(12). 1442–1449. 23 indexed citations
7.
Thomas, Renee M., Ryan Gillihan, & María Isabel Longo. (2019). Successful treatment of recalcitrant molluscum contagiosum in a stem cell transplant patient with Candida immunotherapy. Dermatologic Therapy. 32(5). e12999–e12999. 5 indexed citations
8.
Suppa, Mariano, Sara Gandini, H. Njimi, et al.. (2019). Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign. Journal of the European Academy of Dermatology and Venereology. 33(S2). 76–88. 12 indexed citations
9.
Longo, María Isabel, Jean‐Luc Bulliard, Osvaldo Correia, et al.. (2019). Sunbed use legislation in Europe: assessment of current status. Journal of the European Academy of Dermatology and Venereology. 33(S2). 89–96. 9 indexed citations
10.
Suppa, Mariano, Sara Gandini, Jean‐Luc Bulliard, et al.. (2019). Who, why, where: an overview of determinants of sunbed use in Europe. Journal of the European Academy of Dermatology and Venereology. 33(S2). 6–12. 18 indexed citations
11.
Suppa, Mariano, Sara Gandini, H. Njimi, et al.. (2019). Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign. Journal of the European Academy of Dermatology and Venereology. 33(S2). 13–27. 29 indexed citations
12.
Nielson, Colton B., et al.. (2018). Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients. Dermatologic Therapy. 32(2). e12803–e12803. 11 indexed citations
13.
Longo, María Isabel, et al.. (2018). Hypopyon pustules of Sneddon‐Wilkenson disease. International Journal of Dermatology. 58(5). 605–606.
14.
Longo, María Isabel, et al.. (2016). A First Case Description of Adrenal Gland Tumour in a Lion (Panthera Leo): Tomographic and Clinico-Pathological Findings. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 82–85. 1 indexed citations
15.
Wozniak, Magdalena B., Raquel Villuendas, James R. Bischoff, et al.. (2010). Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. Haematologica. 95(4). 613–621. 86 indexed citations
16.
Schuster, James M., María Isabel Longo, & Peter S. Nelson. (2003). Differential Expression of Bikunin (HAI-2/PB), A Proposed Mediator of Glioma Invasion, by Demethylation Treatment. Journal of Neuro-Oncology. 64(3). 219–225. 12 indexed citations
17.
Longo, María Isabel, et al.. (2000). Dark-Red Plaques on the Scalp of a Newborn. Archives of Dermatology. 136(12). 1559–1559.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026